Published in J Intern Med on August 01, 2006
Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Res Treat (2013) 7.11
Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat (2015) 6.31
Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011. Cancer Res Treat (2014) 5.97
Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009. Cancer Res Treat (2012) 5.07
Cancer survival in Korea 1993-2002: a population-based study. J Korean Med Sci (2007) 4.36
Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008. Cancer Res Treat (2011) 4.21
Cancer statistics in Korea: incidence, mortality and survival in 2006-2007. J Korean Med Sci (2010) 3.79
Cancer statistics in Korea: incidence, mortality and survival in 2005. J Korean Med Sci (2009) 2.61
Success story of targeted therapy in chronic myeloid leukemia: a population-based study of patients diagnosed in Sweden from 1973 to 2008. J Clin Oncol (2011) 2.34
Screening and cervical cancer cure: population based cohort study. BMJ (2012) 1.99
Acute myeloid leukemia in the real world: why population-based registries are needed. Blood (2012) 1.67
Patterns of survival among patients with myeloproliferative neoplasms diagnosed in Sweden from 1973 to 2008: a population-based study. J Clin Oncol (2012) 1.46
Melanoma survival in the United States, 1992 to 2005. J Am Acad Dermatol (2011) 1.44
Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study. Haematologica (2009) 1.19
Survival improvement in patients with pancreatic cancer by decade: a period analysis of the SEER database, 1981-2010. Sci Rep (2014) 1.14
Outcome of older patients with acute myeloid leukemia: an analysis of SEER data over 3 decades. Cancer (2013) 1.11
Evaluation of North American Association of Central Cancer Registries' (NAACCR) data for use in population-based cancer survival studies. J Natl Cancer Inst Monogr (2014) 1.09
Age-specific trends in morbidity, mortality and case-fatality from cardiovascular disease, myocardial infarction and stroke in advanced age: evaluation in the Swedish population. PLoS One (2013) 1.03
When do changes in cancer survival mean progress? The insight from population incidence and mortality. J Natl Cancer Inst Monogr (2014) 1.00
Explanations for worsening cancer survival. Nat Rev Clin Oncol (2010) 0.99
Development of a survey instrument to investigate the primary care factors related to differences in cancer diagnosis between international jurisdictions. BMC Fam Pract (2014) 0.99
Should relative survival be used with lung cancer data? Br J Cancer (2012) 0.98
Estimating and modelling cure in population-based cancer studies within the framework of flexible parametric survival models. BMC Med Res Methodol (2011) 0.97
German cancer statistics 2004. BMC Cancer (2010) 0.93
The effect of multiple primary rules on population-based cancer survival. Cancer Causes Control (2013) 0.91
Do Asian breast cancer patients have poorer survival than their western counterparts? A comparison between Singapore and Stockholm. Breast Cancer Res (2009) 0.89
Survival from colorectal cancer in Germany in the early 21st century. Br J Cancer (2012) 0.88
Factors affecting long-term survival after surgical resection of pancreatic ductal adenocarcinoma. J Korean Surg Soc (2011) 0.86
Survival improvement by decade of patients aged 0-14 years with acute lymphoblastic leukemia: a SEER analysis. Sci Rep (2014) 0.86
Survival analysis in hematologic malignancies: recommendations for clinicians. Haematologica (2014) 0.83
Incidence, mortality and survival patterns of prostate cancer among residents in Singapore from 1968 to 2002. BMC Cancer (2008) 0.83
Follicular lymphoma in Sweden: nationwide improved survival in the rituximab era, particularly in elderly women: a Swedish Lymphoma Registry study. Leukemia (2014) 0.81
Treatment, trial participation and survival in adult acute myeloid leukemia: a population-based study in the Netherlands, 1989-2012. Leukemia (2015) 0.80
Coding completeness and quality of relative survival-related variables in the National Program of Cancer Registries Cancer Surveillance System, 1995-2008. J Registry Manag (2014) 0.79
Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival. J Natl Cancer Inst (2017) 0.78
Disparate survival trends in histologic subtypes of metastatic non-small cell lung cancer: a population-based analysis. Am J Cancer Res (2015) 0.78
The impact of second primary malignancies on head and neck cancer survivors: a nationwide cohort study. PLoS One (2013) 0.77
Gastric adenocarcinoma incidence in the province of Messina (Insular Italy): A cancer registry study. Oncol Lett (2013) 0.77
Improved survival for non-Hodgkin lymphoma patients in New South Wales, Australia. BMC Cancer (2010) 0.76
Relative survival analysis using the Centers for Disease Control and Prevention's National Program of Cancer Registries Surveillance System Data, 2000-2007. J Registry Manag (2014) 0.76
Effect of low-dose aspirin use on survival of patients with gastrointestinal malignancies; an observational study. Br J Cancer (2017) 0.75
Continued improvement in survival of acute myeloid leukemia patients: an application of the loss in expectation of life. Blood Cancer J (2016) 0.75
Increasing Disadvantages in Cancer Survival in New Zealand Compared to Australia, between 2000-05 and 2006-10. PLoS One (2016) 0.75
The loss in expectation of life after colon cancer: a population-based study. BMC Cancer (2015) 0.75
Improved survival in primary central nervous system lymphoma up to age 70 only: A population-based study on incidence, primary treatment and survival in the Netherlands, 1989-2015. Leukemia (2017) 0.75
Construction of a North American Cancer Survival Index to Measure Progress of Cancer Control Efforts. Prev Chronic Dis (2017) 0.75
TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort. Oncogene (2007) 5.79
Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer (2003) 2.64
Low carbohydrate-high protein diet and mortality in a cohort of Swedish women. J Intern Med (2007) 2.12
Tobacco use and cancer causation: association by tumour type. J Intern Med (2002) 1.91
Lifestyle prescriptions for cancer survivors and their communities. J Intern Med (2010) 1.68
Tobacco use, cancer causation and public health impact. J Intern Med (2002) 1.64
Prospects for chemoprevention of cancer. J Intern Med (2002) 1.58
The NordICC Study: rationale and design of a randomized trial on colonoscopy screening for colorectal cancer. Endoscopy (2012) 1.44
Alcohol abuse and the risk of pancreatic cancer. Gut (2002) 1.35
Dietary acrylamide and cancer of the large bowel, kidney, and bladder: absence of an association in a population-based study in Sweden. Br J Cancer (2003) 1.24
Genetic variation in the COX-2 gene and the association with prostate cancer risk. Int J Cancer (2006) 1.23
Diabetes therapy and cancer risk: causal effects and other plausible explanations. Diabetologia (2010) 1.21
Diet during pregnancy in relation to maternal weight gain and birth size. Eur J Clin Nutr (2004) 1.05
Correlates of pregnancy oestrogen, progesterone and sex hormone-binding globulin in the USA and China. Eur J Cancer Prev (2002) 1.05
Correlation of umbilical cord blood haematopoietic stem and progenitor cell levels with birth weight: implications for a prenatal influence on cancer risk. Br J Cancer (2008) 1.02
Prospective study of body size and risk for stroke amongst women below age 60. J Intern Med (2006) 1.01
Risk for invasive and borderline epithelial ovarian neoplasias following use of hormonal contraceptives: the Norwegian-Swedish Women's Lifestyle and Health Cohort Study. Br J Cancer (2004) 1.00
Early anthropometric measures and reproductive factors as predictors of body mass index and obesity among older women. Int J Obes (Lond) (2005) 0.95
Dietary fat and breast cancer risk in the Swedish women's lifestyle and health cohort. Br J Cancer (2007) 0.94
Breast cancer prognosis in relation to family history of breast and ovarian cancer. Br J Cancer (2004) 0.92
Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk. Br J Cancer (2005) 0.91
Suicide and suicide attempt after a cancer diagnosis among young individuals. Ann Oncol (2013) 0.89
Gene variations in sex hormone pathways and the risk of testicular germ cell tumour: a case-parent triad study in a Norwegian-Swedish population. Hum Reprod (2012) 0.88
A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment. Cancer Epidemiol Biomarkers Prev (2007) 0.86
Paraquat and Parkinson's disease: an overview of the epidemiology and a review of two recent studies. Regul Toxicol Pharmacol (2011) 0.85
Obesity and risk of pancreatic cancer among postmenopausal women: the Women's Health Initiative (United States). Br J Cancer (2008) 0.83
Genetic variation in AKT1, PTEN and the 8q24 locus, and the risk of testicular germ cell tumor. Hum Reprod (2013) 0.81
Maternal and gestational correlates of pregnancy prolactin and growth hormone in USA and China. Eur J Cancer Prev (2003) 0.80
Novel measurements of mammary stem cells in human umbilical cord blood as prospective predictors of breast cancer susceptibility in later life. Ann Oncol (2011) 0.79
No excess risk of colorectal cancer among alcoholics followed for up to 25 years. Br J Cancer (2003) 0.78
Early life exposure to oestrogen and testicular cancer risk: evidence against an aetiological hypothesis. Br J Cancer (2002) 0.78
Neonatal growth and breast cancer risk in adulthood. Br J Cancer (2008) 0.75